Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method

doi:10.5493/wjem.v15.i3.108984

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (303)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

179

Figures (1-5)

Tables (1-2)

Sum=218

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=73

Publishing Process of This Article

Item

Count

Browse

Download

Sum=15

Sep 20, 2025 (publication date) through Aug 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Exp Med. Sep 20, 2025; 15(3): 108984
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.108984

Full Size Figure Download Figure

Figure 1 Distribution of patients with breast cancer. A: According to T and N stages and tumor grade; B: According to their molecular and biological characteristics. Abbreviations: ER: Estrogen receptor; HER2: Human epidermal growth factor receptor-2; PR: Progesterone receptor; TNBC: Triple negative breast cancer.

Citation: Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. World J Exp Med 2025; 15(3): 108984
URL: https://www.wjgnet.com/2220-315X/full/v15/i3/108984.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i3.108984